MedTrace Logo

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

NCT06373744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 597

Last updated 2024-04-18

No results posted yet for this study

Summary

The goal of this observational study is to learn about the effects of metronomic chemotherapy in advanced breast cancer patients. The main question it aims to answer is:

How effective is metronomic chemotherapy in advanced breast cancer? Specific benefit groups of metronomic chemotherapy.

Conditions

Interventions

DRUG

cyclophosphamide , methotrexate , vinorelbine ,capecitabine

The drugs used in metronomic chemotherapy are cyclophosphamide (CTX), methotrexate (M), vinorelbine (VNR), and capecitabine

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Shusen Wang, MD · Sun Yat-sen University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06373744 on ClinicalTrials.gov